Cover Image

INCIDENCE OF CENTRAL SEROUS CHORIORETINOPATHY IN FEMALE POPULATION.

SANGAMITHIRA M

Abstract


AIM-To study the predisposing factors, clinical features and outcome of central serous chorioretinopathy (CSCR) in a female population. METHODS-Records of  female patients more than 20 years of age attended the retina clinic with a clinical diagnosis of CSCR between Jan 2013 to Jan2014 were reviewed. Data collected include predisposing factors, visual acuity at presentation, fundus fluorescein    angiographic features, optical coherence tomography    features, time for resolution and final outcome. RESULTS Data on 37 eyes of 37 patients were analysed. Females  comprised 21.4 of population with CSCR during the study period (37 of 173 patients). Mean age was 42.8 years (range 23-51 yrs) which was significantly greater than that in males. Common predisposing factors were steroid use (24),             pregnancy(16), and hypertension (10). Ink blot leak was the commonest fundus fluorescence angiogram finding FFA is43. Mean time to resolution was 2 months which was significantly higher than that in males. CONCLUSION - CSCR tends to occur in older women when compared to men and time to resolution is more prolonged. Steroid use and pregnancy are the important risk factors.

 


Full Text:

PDF

References


vonGraefe, A. Ueber central recidivierende retinitis. Graefes Arch ClinExpOphthalmol. 1866;12:211-215.

Kitzmann AS, Pulido JS, Diehl NN et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008;115:169-173.

Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;1111:244-249.

Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109:1834-1837.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University